Alcohol Addiction - Pipeline Review, H2 2018

  • ID: 4590341
  • Drug Pipelines
  • 151 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • AstraZeneca Plc
  • Corcept Therapeutics Inc
  • H. Lundbeck AS
  • Kinnov Therapeutics SAS
  • Omeros Corp
  • MORE
Alcohol Addiction - Pipeline Review, H2 2018

Summary:

This latest Pharmaceutical and Healthcare disease pipeline guide Alcohol Addiction - Pipeline Review, H2 2018, provides an overview of the Alcohol Addiction (Central Nervous System) pipeline landscape.

Alcohol addiction refers to a psychological and physical dependency on alcohol. Symptoms include decreased involvement in extracurricular activities, depression, restlessness, inability to control drinking and violent behavior. Risk factors include age, family history and depression and other mental health problems.

Report Highlights:

This latest pipeline guide Alcohol Addiction - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Alcohol Addiction (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Alcohol Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alcohol Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 2, 11, 5, 1, 20 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 5 molecules, respectively.

Alcohol Addiction (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Alcohol Addiction (Central Nervous System).
  • The pipeline guide reviews pipeline therapeutics for Alcohol Addiction (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Alcohol Addiction (Central Nervous System) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Alcohol Addiction (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Alcohol Addiction (Central Nervous System)
Reasons for Purchase:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Alcohol Addiction (Central Nervous System).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Alcohol Addiction (Central Nervous System) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • AstraZeneca Plc
  • Corcept Therapeutics Inc
  • H. Lundbeck AS
  • Kinnov Therapeutics SAS
  • Omeros Corp
  • MORE
Introduction

Alcohol Addiction - Overview

Alcohol Addiction - Therapeutics Development

Alcohol Addiction - Therapeutics Assessment

Alcohol Addiction - Companies Involved in Therapeutics Development

Alcohol Addiction - Drug Profiles

Alcohol Addiction - Dormant Projects

Alcohol Addiction - Discontinued Products

Alcohol Addiction - Product Development Milestones

Appendix

List of Tables

Number of Products under Development for Alcohol Addiction, H2 2018

Number of Products under Development by Companies, H2 2018

Number of Products under Development by Companies, H2 2018 (Contd..1), H2 2018

Number of Products under Development by Universities/Institutes, H2 2018

Products under Development by Companies, H2 2018

Products under Development by Companies, H2 2018 (Contd..1), H2 2018

Products under Development by Companies, H2 2018 (Contd..2), H2 2018

Products under Development by Universities/Institutes, H2 2018

Number of Products by Stage and Target, H2 2018

Number of Products by Stage and Target, H2 2018 (Contd..1), H2 2018

Number of Products by Stage and Mechanism of Action, H2 2018

Number of Products by Stage and Mechanism of Action, H2 2018 (Contd..1), H2 2018

Number of Products by Stage and Route of Administration, H2 2018

Number of Products by Stage and Molecule Type, H2 2018

Alcohol Addiction - Pipeline by AbbVie Inc, H2 2018

Alcohol Addiction - Pipeline by Addex Therapeutics Ltd, H2 2018

Alcohol Addiction - Pipeline by Adial Pharmaceuticals LLC, H2 2018

Alcohol Addiction - Pipeline by Arbor Pharmaceuticals LLC, H2 2018

Alcohol Addiction - Pipeline by AstraZeneca Plc, H2 2018

Alcohol Addiction - Pipeline by BioCorRx Inc, H2 2018

Alcohol Addiction - Pipeline by Bionex Pharmaceuticals LLC, H2 2018

Alcohol Addiction - Pipeline by Bioprojet SCR, H2 2018

Alcohol Addiction - Pipeline by Chronos Therapeutics Ltd, H2 2018

Alcohol Addiction - Pipeline by Corcept Therapeutics Inc, H2 2018

Alcohol Addiction - Pipeline by Curemark LLC, H2 2018

Alcohol Addiction - Pipeline by Eli Lilly and Co, H2 2018

Alcohol Addiction - Pipeline by Ethypharm SA, H2 2018

Alcohol Addiction - Pipeline by H. Lundbeck AS, H2 2018

Alcohol Addiction - Pipeline by Heptares Therapeutics Ltd, H2 2018

Alcohol Addiction - Pipeline by Indivior Plc, H2 2018

Alcohol Addiction - Pipeline by Johnson & Johnson, H2 2018

Alcohol Addiction - Pipeline by Kinnov Therapeutics SAS, H2 2018

Alcohol Addiction - Pipeline by Kyorin Pharmaceutical Co Ltd, H2 2018

Alcohol Addiction - Pipeline by Lohocla Research Corp, H2 2018

Alcohol Addiction - Pipeline by Mapreg SAS, H2 2018

Alcohol Addiction - Pipeline by Montisera Ltd, H2 2018

Alcohol Addiction - Pipeline by Omeros Corp, H2 2018

Alcohol Addiction - Pipeline by Opiant Pharmaceuticals Inc, H2 2018

Alcohol Addiction - Pipeline by Pfizer Inc, H2 2018

Alcohol Addiction - Pipeline by Silence Therapeutics Plc, H2 2018

Alcohol Addiction - Pipeline by SK Biopharmaceuticals Co Ltd, H2 2018

Alcohol Addiction - Pipeline by Syntropharma Ltd, H2 2018

Alcohol Addiction - Pipeline by Tonix Pharmaceuticals Holding Corp, H2 2018

Alcohol Addiction - Pipeline by Zynerba Pharmaceuticals Inc, H2 2018

Alcohol Addiction - Dormant Projects, H2 2018

Alcohol Addiction - Dormant Projects, H2 2018 (Contd..1), H2 2018

Alcohol Addiction - Dormant Projects, H2 2018 (Contd..2), H2 2018

Alcohol Addiction - Discontinued Products, H2 2018

List of Figures

Number of Products under Development for Alcohol Addiction, H2 2018

Number of Products under Development by Companies, H2 2018

Number of Products by Top 10 Targets, H2 2018

Number of Products by Stage and Top 10 Targets, H2 2018

Number of Products by Top 10 Mechanism of Actions, H2 2018

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018

Number of Products by Routes of Administration, H2 2018

Number of Products by Stage and Routes of Administration, H2 2018

Number of Products by Molecule Types, H2 2018

Number of Products by Stage and Molecule Types, H2 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • AbbVie Inc
  • Addex Therapeutics Ltd
  • Adial Pharmaceuticals LLC
  • Arbor Pharmaceuticals LLC
  • AstraZeneca Plc
  • BioCorRx Inc
  • Bionex Pharmaceuticals LLC
  • Bioprojet SCR
  • Chronos Therapeutics Ltd
  • Corcept Therapeutics Inc
  • Curemark LLC
  • Eli Lilly and Co
  • Ethypharm SA
  • H. Lundbeck AS
  • Heptares Therapeutics Ltd
  • Indivior Plc
  • Johnson & Johnson
  • Kinnov Therapeutics SAS
  • Kyorin Pharmaceutical Co Ltd
  • Lohocla Research Corp
  • Mapreg SAS
  • Montisera Ltd
  • Omeros Corp
  • Opiant Pharmaceuticals Inc
  • Pfizer Inc
  • Silence Therapeutics Plc
  • SK Biopharmaceuticals Co Ltd
  • Syntropharma Ltd
  • Tonix Pharmaceuticals Holding Corp
  • Zynerba Pharmaceuticals Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll